Demyelination Multiple Sclerosis

Featured Health Expert
19065
EXPERT

Does the demyelination from multiple sclerosis affect your ability to walk?

If so, then Acorda Therapeutics, Inc. would like you to know that on January 30, 2009, they submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Fampridine-SR, a novel therapy developed to “improve walking ability” in people with multiple sclerosis.

 

Fampridine-SR is a sustained-release tablet formulation of the investigational drug fampridine (4-aminopyridine or 4-AP). In laboratory studies, fampridine has been found to improve impulse conduction in...

Read more

More information on "Demyelination Multiple Sclerosis"

From Our Experts

See more SharePosts »

From Our Sources

More on Multiple Sclerosis »